These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 11814239)
1. Influence of dendritic cells on the in vitro allogeneic cytotoxic reaction of lymphoid cells derived from normal or Listeria innocua-infected BALB/c mice. Gościcka T; Walencka M; Fol M; Krupa A; Szeliga J Arch Immunol Ther Exp (Warsz); 2001; 49(6):447-52. PubMed ID: 11814239 [TBL] [Abstract][Full Text] [Related]
2. Interleukin 12 and direct cytotoxicity of spleen lymphocytes to Listeria innocua-phagocyting syngeneic macrophages in C57BL/6 and BALB/c mice. Szeliga J; Fiuk D; Walencka M; Gościcka T Arch Immunol Ther Exp (Warsz); 1997; 45(1):49-54. PubMed ID: 9090440 [TBL] [Abstract][Full Text] [Related]
3. Participation of IL-2 and direct cell cytotoxicity in the modulation of GvH reaction in mice infected with Listeria innocua. Gościcka T; Walencka M; Szeliga J; Bloch M; Dziadek B Arch Immunol Ther Exp (Warsz); 1995; 43(5-6):239-45. PubMed ID: 8744642 [TBL] [Abstract][Full Text] [Related]
4. Immunomodulatory effect of Listeria monocytogenes infection. II. Natural cell cytotoxicity in infected mice. Gościcka T; Walencka M Arch Immunol Ther Exp (Warsz); 1986; 34(5-6):479-88. PubMed ID: 3109349 [TBL] [Abstract][Full Text] [Related]
5. Splenic dendritic cells pulsed with Ixodes ricinus tick saliva prime naive CD4+T to induce Th2 cell differentiation in vitro and in vivo. Mejri N; Brossard M Int Immunol; 2007 Apr; 19(4):535-43. PubMed ID: 17344202 [TBL] [Abstract][Full Text] [Related]
6. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen. Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645 [TBL] [Abstract][Full Text] [Related]
7. [Allogeneic dendritic cell vaccine pulsed with heat shocked tumor cell lysate can enhance antitumor immunity]. You J; Wang CL; Hao XS Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2785-90. PubMed ID: 18167273 [TBL] [Abstract][Full Text] [Related]
8. Unique functions of splenic CD8alpha+ dendritic cells during infection with intracellular pathogens. Neuenhahn M; Busch DH Immunol Lett; 2007 Dec; 114(2):66-72. PubMed ID: 17964665 [TBL] [Abstract][Full Text] [Related]
9. Comparative evaluation of CC chemokine-induced migration of murine CD8alpha+ and CD8alpha- dendritic cells and their in vivo trafficking. Colvin BL; Morelli AE; Logar AJ; Lau AH; Thomson AW J Leukoc Biol; 2004 Feb; 75(2):275-85. PubMed ID: 14597730 [TBL] [Abstract][Full Text] [Related]
10. [Changes in immune function of dendritic cells infected by recombinant adenovirus containing Her2/neu gene of extracellular and transmembrane domain proteins]. Ma SD; Luo RC; Ding ZH; Lu F; Yuan CQ Nan Fang Yi Ke Da Xue Xue Bao; 2006 Aug; 26(8):1184-7. PubMed ID: 16939917 [TBL] [Abstract][Full Text] [Related]
11. Splenic dendritic cell subsets prime and boost CD8 T cells and are involved in the generation of effector CD8 T cells. Behboudi S; Moore A; Hill AV Cell Immunol; 2004 Mar; 228(1):15-9. PubMed ID: 15203315 [TBL] [Abstract][Full Text] [Related]
12. Anti-tumor immunity against nasopharyngeal carcinoma by means of LMP2A-specific cytotoxic T lymphocytes induced by dendritic cells. Xu JJ; Yao K; Yu CJ; Chen X; Lu MP; Sun H; Li BZ; Ding CN; Zhou F Auris Nasus Larynx; 2006 Dec; 33(4):441-6. PubMed ID: 16934422 [TBL] [Abstract][Full Text] [Related]
14. Immunosuppressive effect of pregnant mouse serum on allostimulatory activity of dendritic cells. Shojaeian J; Moazzeni SM; Nikoo S; Bozorgmehr M; Nikougoftar M; Zarnani AH J Reprod Immunol; 2007 Aug; 75(1):23-31. PubMed ID: 17434209 [TBL] [Abstract][Full Text] [Related]
15. Dendritic cell-tumor cell hybrids enhance the induction of cytotoxic T lymphocytes against murine colon cancer: a comparative analysis of antigen loading methods for the vaccination of immunotherapeutic dendritic cells. Yasuda T; Kamigaki T; Nakamura T; Imanishi T; Hayashi S; Kawasaki K; Takase S; Ajiki T; Kuroda Y Oncol Rep; 2006 Dec; 16(6):1317-24. PubMed ID: 17089056 [TBL] [Abstract][Full Text] [Related]
16. Differential capacity of CD8+ alpha or CD8- alpha dendritic cell subsets to prime for eosinophilic airway inflammation in the T-helper type 2-prone milieu of the lung. Hammad H; de Vries VC; Maldonado-Lopez R; Moser M; Maliszewski C; Hoogsteden HC; Lambrecht BN Clin Exp Allergy; 2004 Dec; 34(12):1834-40. PubMed ID: 15663556 [TBL] [Abstract][Full Text] [Related]
17. [Immunotherapy against tumor with dendritic cell sensitized by necrotic tumor tissue after microwave coagulation therapy]. Yao LC; Yang RJ Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(36):2552-6. PubMed ID: 18067832 [TBL] [Abstract][Full Text] [Related]
18. Dendritic cells in germ-free and specific pathogen-free mice have similar phenotypes and in vitro antigen presenting function. Walton KL; He J; Kelsall BL; Sartor RB; Fisher NC Immunol Lett; 2006 Jan; 102(1):16-24. PubMed ID: 16105690 [TBL] [Abstract][Full Text] [Related]
19. IL-4 deficiency does not impair the ability of dendritic cells to initiate CD4+ and CD8+ T cell responses in vivo. Roberts JM; Yang J; Ronchese F Int Immunol; 2004 Oct; 16(10):1451-8. PubMed ID: 15326095 [TBL] [Abstract][Full Text] [Related]
20. Dendritic cells engineered to express the Flt3 ligand stimulate type I immune response, and induce enhanced cytoxic T and natural killer cell cytotoxicities and antitumor immunity. Liu Y; Huang H; Chen Z; Zong L; Xiang J J Gene Med; 2003 Aug; 5(8):668-80. PubMed ID: 12898636 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]